submit to the journals

COPD Journal Articles, Videos And Insights

COPD: FEATURED Articles

flipper_slider

COPD: INSIGHTS

The touchRESPIRATORY website provides a selection of resources to inform clinicians and patients about the latest developments in the field. The following are quick, non peer-reviewed, opinion-based updates addressing current trends and opinion on the most recent advances in the area of respiratory medicine:

Insight
Highlights from the ATS International Congress 2018—Focus on COPD Alex Lowe, Senior Medical Writer, Touch Medical Media, UK
Abraham Choong, Account Director and Advisory Editor, Touch Medical Media, UK
Insights into COPD research presented at American Thoracic Society International Congress, San Diego, CA, US, May 18–23, 2018.
Insight
Highlights from the ERS International Congress 2017: focus on COPD Katrina Mountfort, Senior Medical Writer, Touch Medical Media, UK
Matthew Goodwin, Respiratory Business Unit Director, Touch Medical Media, UK

Insight
The FLAME trial: a new landmark in the management of COPD Katrina Mountfort, Senior Medical Writer, Touch Medical Media, UK
Insight
Reducing hospital admissions in COPD Katrina Mountfort, Freelance Medical Writer for Touch Medical Media, UK

COPD: FEATURED VIDEOS

Editor's choice

Satellite Symposium Highlights: New Non-invasive COPD Screening of EFL Within Home Therapy Symposium sponsored by Philips Respironics Filmed at the ERCA–JIVD 3rd Joint International Meeting, Lyon, France, March 2018 **Click on image to start viewing video interview** Peter Calverley, Professor of Respiratory Medicine and Honorary Consultant Respiratory Physician at Aintree Hospitals, Liverpool, UK, responds to the following questions: 1. What is the importance of evaluating expiratory flow limitation (EFL) in patients with COPD? (0:10) 2. Is it important to screen for EFL in different postures (seated, supine)? (0:50) 3. What is currently used to evaluate EFL in patients with COPD? (1:20) 4. What are the advantages and disadvantages of using of DeltaXRS/FOT compared with spirometry and esophageal balloon tests? (2:22) 5. How does treating EFL impact work of breathing (WOB) issues at rest? (3:17) 6. What do you feel will be the biggest obstacles or gaps in treating EFL in ambulatory/home patients with COPD? (4:14) Speaker disclosures: Peter Calverley has nothing to disclose in relation to this video interview. Filming support: Educational grant from Philips Respironics. View the satellite symposium in full, here. View an interview with speaker Raffaele L Dellacà, here. View an interview with chairperson David White, here. View an interview with speaker Robert Romano, here.
Prof. Nicholas Hart discusses the findings and clinical implications of the Home Oxygen Therapy – Home Mechanical Ventilation (HOT-HMV) trial, which offers new hope to patients with COPD. For a review of a symposium presented at ERS 2016, plus the HOT-HMV study findings presented at ATS and published in JAMA in June 2017, please click here. Speaker disclosure: Nicholas Hart reports grants from Guy’s & St Thomas’ Charity, during the conduct of the study; grants from Philips Respironics, ResMed, B&D Electromedical and Fisher-Paykel; non-financial support from Philips Respironics RT Meeting (MyoTrace) and personal fees from Fisher-Paykel, outside the submitted work. In addition, Nicholas Hart has a patent for MyoTrace pending and he is on the Pulmonary Research Advisory Board for Philips. His Lane Fox Clinical Respiratory Physiology Research Group has received unrestricted grants (managed by Guy’s & St Thomas’ Foundation Trust) from Philips Respironics, Philips, ResMed, Fisher-Paykel and B&D Electromedical. Philips Respironics and Philips Research are contributing to the development of the MyoTrace Technology. Filmed at the American Thoracic Society (ATS) International Conference, Washington DC, US, May 2017.

COPD: Latest Videos

Video List based on Category on Node Page

Latest Videos

Editorial board member Mario Cazzola (University of Rome Tor Vergata, Rome, Italy) discusses the background and findings of his late-breaking presentation entitled: Impact of ICS/LABA and LABA/LAMA FDCs on lung function and exacerbation of COPD: a network meta-analysis. Questions 1. Why was...
Editorial board member Daniel R Ouellette (Wayne State University School of Medicine, Detroit, MI, US) considers what is known to-date about the impact of e-cigarettes or vaping versus traditional tobacco products on respiratory disease. Questions 1. What is the overall effect on respiratory...
David White (Philips Sleep & Respiratory Care, Denver, CO, US) discusses the rationale for combining home oxygen therapy (HOT) with home mechanical ventilation (HMV) in the HOT-HMV study, and describes findings of two new economic analyses presented during the meeting: Cost-Effectiveness...
Nicola A Hanania (Baylor College of Medicine, TX, US) is a valued member of our Editorial Board for US Respiratory & Pulmonary Diseases. Here he discusses with us the background and findings of his presentation entitled: What Symptomatic Patients with Asthma and Chronic Obstructive Pulmonary...
Nicola A Hanania (Baylor College of Medicine, TX, US) is a valued member of our Editorial Board for US Respiratory & Pulmonary Diseases. He describes how inhalers in asthma and COPD are often misused and this issue can be avoided. He also considers factors that affect adherence with inhaler...
Nicola A Hanania (Baylor College of Medicine, TX, US) is a valued member of our Editorial Board for US Respiratory & Pulmonary Diseases. He discusses the different types of inhaler systems available for asthma and COPD, recommendations regarding these different delivery platforms and factors...

LATEST TWEETS

Conference Highlights